Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
ENAVATE SCIENCES GP, LLC (CIK 1953107) reported $345.4M across 7 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: SION ($109.0M, 31.56%), ZBIO ($99.5M, 28.80%), IMNM ($76.6M, 22.17%), BBOT ($20.0M, 5.80%), CMPX ($17.1M, 4.94%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SION | SIONNA THERAPEUTICS INC | $109.0M | 31.56% | 2.5M | Hold |
| 2 | ZBIO | ZENAS BIOPHARMA INC | $99.5M | 28.80% | 3.9M | Hold |
| 3 | IMNM | IMMUNOME INC | $76.6M | 22.17% | 3.6M | Hold |
| 4 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $20.0M | 5.80% | 2.6M | Hold |
| 5 | CMPX | COMPASS THERAPEUTICS INC | $17.1M | 4.94% | 7.8M | Hold |
| 6 | UPB | UPSTREAM BIO INC | $17.0M | 4.93% | 2.5M | Hold |
| 7 | CAMP | CAMP4 THERAPEUTICS CORP | $6.2M | 1.80% | 1.4M | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30